Gain Funding to Promote Your Research
The ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award provides $25,000 of support to eligible investigators for a mentored research project exploring the role of nuclear cardiology in the early detection of TTR cardiac amyloidosis.
The recipient will have the distinct honor of presenting the status of their research at the 31st Annual Scientific Session and Exhibition of the American Society of Nuclear Cardiology, to be held Sept. 2026.
The call for applications is now closed.
Award Info
Goals
- Increase opportunities for clinical research focused on cardiac amyloidosis and to improve early diagnosis, timely referral to amyloid experts, and knowledge of emerging treatment options.
- Improve outcomes of patients with ATTR-CM.
- Encourage and support careers in nuclear cardiology research while growing the science of cardiac imaging and advancing the specialty.
Objectives
- Promote research in nuclear cardiology among young investigators.
- Create platform for research projects in the area of advancing early detection of TTR cardiac amyloidosis utilizing nuclear cardiology.
- Provide an "initial" grant for young investigators that will serve as a stepping stone to larger awards.
- Promote the field of nuclear cardiology by supporting new and innovative research.
Award Amount/Project Duration
$25,000 for one year
Number of Awards
One (1)
Application Deadline
June 30, 2025
Award Eligibility
Individuals who:
- Hold an MD, PhD or equivalent degree
- Are post-doctoral fellows or faculty in the first three years of appointment on the date of the application deadline
- Intend to pursue an academic career in nuclear cardiology
- Have an active ASNC membership
Individuals with prior independent investigator awards (e.g., NIH, R0l) will not be eligible to apply for this funding. The applicant may not have current overlapping funding from another organization to supplement their proposed work.
Judging Criteria
Applications will be reviewed against the following criteria:
- Scientific merit (significance) with focus on the potential for the project to generate data for a successful peer-reviewed grant application
- Approach/methods
- Innovation and role in early detection or monitoring of TTR cardiac amyloidosis
- Investigator qualifications with focus on the potential for the principal investigator to develop into an independent investigator
- Quality of mentor and training environment – letter of reference from mentor
- Research benefit for the field of nuclear cardiology
A rating scale such as the one below will be utilized by the award committee for scoring each application. A numerical scoring system from 1.0 to 5.0 -- 1.0 is highest; 2.5 is mid-range; 5.0 is lowest.
Expectations of the Awardee
You will use the full $25,000 award during the one-year term of the award. All unexpended funds at the end of the term are to be returned to ASNC. Extensions or changes to the terms of the award (length of funding period and budget) will only be made in exceptional circumstances.
- You must submit 1) a progress and financial report on or before February, 28, 2026, describing your work to date, and 2) your final research and finance reports on or before August 15, 2026.
- You are expected to report the results of your work with your mentor during an educational session at the 31st Annual Scientific Session and Exhibition of the American Society of Nuclear Cardiology, to be held Sept. 2026 in Las Vegas, Nevada.
- All publications, presentations, and products resulting from this research should acknowledge the ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Award.
2024
Jamilah Alharbi, MD
2023
Dia A. Smiley, DO
2022
Olivier F. Clerc, MD
2021
Ramsey M. Wehbe, MD, MSAI
2020
Vasvi Singh, MD, FASNC
